Medical Progress Today
mpt home | sign up

Volume 4, Number 3
January 19, 2007


PRINTER FRIENDLY

News

Second Drop in Cancer Deaths Could Point to a Trend, Researchers Say
The New York Times, 1-18-07

Editor's Notes:

For the second consecutive year, cancer deaths in the U.S. declined, outpacing both population growth and aging. Experts attributed much of the decline to better detection and treatment of cancer, particularly for "colorectal, breast, and prostate cancers."
Continue reading . . .

Area drug firms go to war over vaccine
The Philadelphia Inquirer, 1-18-07

Editor's Notes:

Over the past several years, drugmakers have increasingly embraced the idea of head–to–head studies between competing products in the hopes of gaining an edge in price or formulary position with insurers. For the first time, vaccine manufacturers seem to be embracing the idea, with GSK announcing that it would sponsor a trial pitting its new cervical cancer vaccine against a rival formulation made by Merck.
Continue reading . . .

HHS Awards $133M in Flu Vaccine Pacts
Houston Chronicle, 1-17-07

Editor's Notes:

No one knows when—or even if—the H5N1 strain of bird flu will ever mutate sufficiently to become readily transmissible between humans, the precondition for a global pandemic. In the meantime, however, the U.S. government is prudently working with vaccine manufacturers to advance development of potential bird flu vaccines.
Continue reading . . .

FDA Proposes New Measures to Strengthen Drug Safety Under PDUFA Reauthorized User Fee Program
FDA News, 1-11-07

Editor's Notes:

Late last week, the FDA announced the broad outlines of its recommendations to Congress for the reauthorization of the Prescription Drug User Fee Act (PDUFA). As expected, the FDA is requesting significant new resources to enhance postmarket drug surveillance and the ability to levy new fees from companies that ask the agency to review their DTC television spots. Additional details, including an overview of the PDUFA legislation since 1992, is available on the federal register.
Continue reading . . .

Commentary

State plans miss the point
USA Today, 1-15-07

Sally Pipes, president of the San Francisco based Pacific Research Institute, warns that Gov. Schwarzenegger's plan for universal health care coverage in California will flounder on account of high costs and wide–ranging government restrictions on patient choice.
Continue reading . . .

No crisis of the uninsured
Mike Rosen, Rocky Mountain News, 1-12-07

Rosen thinks that the growing national impetus to do "something" about the uninsured overlooks the fact that Americans without health insurance are far from a homogenous or stable group. In fact, the number of Americans who are chronically uninsured is far fewer than is commonly portrayed in the media.
Continue reading . . .

The Real Dangers of Medicare
John Calfee, New York Sun, 1-12-07

Last Friday, the U.S. House of Representatives passed a bill requiring the Secretary of Health and Human Services to negotiate drug prices for medicines covered by the Medicare drug benefit—but it also forbade the Secretary from creating a formulary of covered drugs.
Continue reading . . .

Research

The Value of Antihypertensive Drugs: A perspective on medical innovation
David M. Cutler, Health Affairs, 1-17-07

Cutler and his colleagues estimate the economic and health impacts of antihypertensive therapy in the U.S. over the past 40 years.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

NEWS

Second Drop in Cancer Deaths Could Point to a Trend, Researchers Say
Area drug firms go to war over vaccine
HHS Awards $133M in Flu Vaccine Pacts
FDA Proposes New Measures to Strengthen Drug Safety Under PDUFA Reauthorized User Fee Program

COMMENTARY

State plans miss the point
No crisis of the uninsured
The Real Dangers of Medicare

RESEARCH

The Value of Antihypertensive Drugs: A perspective on medical innovation
Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org